Lynn M Schuchter MD
Hematologic Oncology, Melanoma
Professor of Medicine, University Pennsylvania
Join to View Full Profile
3400 Civic Center BlvdPhiladelphia, PA 19104
Phone+1 215-615-5858
Dr. Schuchter is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lynn Schuchter is an oncologist in Haverford, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and UPMC Presbyterian. She received her medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 35 years. She specializes in hematologic oncology and melanoma and is experienced in sarcomas, melanoma and cutaneous malignancies, and general medical oncology.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1986 - 1989
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1985 - 1986- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982
Certifications & Licensure
PA State Medical License 1989 - 2026
MD State Medical License 1986 - 1989
IL State Medical License 1982 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome Start of enrollment: 1999 Feb 23
- Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma Start of enrollment: 2011 Nov 01
- Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) Start of enrollment: 2014 Jan 24
Publications & Presentations
PubMed
- Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.Shujing Liu, Alain H Rook, Alexander C Huang, Amit Maity, Zhiyuan Qin
Cancer Immunology Research. 2026-06-11 - Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations.Konstantinos Tsingas, Monzy Thomas, McKenna Reale, Min Xiao, Jayamanna Wickramasinghe
Cell Reports. 2026-06-02 - A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma.Shiyou Wei, Yulan Deng, Jinho Lee, Hongbin Lan, Zhenyu Yang
Cell Reports. Medicine. 2026-04-21
Journal Articles
- Effect of Integrating Machine Learning Mortality Estimates with Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients with CancerRavi B Parikh, Justin E Bekelman, Lynn M Schuchter, Lawrence N Shulman, Mitesh S Patel, JAMA Oncology
- Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients with CancerLawrence N Shulman, Lynn M Schuchter, Mitesh S Patel, Ravi B Parikh, JAMA Oncology
- Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 ResponseXiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
Press Mentions
Dr. Nancy Davidson Receives National Cancer AwardJune 4th, 2026- Easing Patient Fears of Radiation Treatment, via Virtual RealityOctober 24th, 2024
- Improving Care for Patients with Acute Lymphocytic LeukemiaJuly 30th, 2024
Grant Support
- Physician Scientist Training in Clinical OncologyUNIVERSITY OF PENNSYLVANIA1997–2030
- Targeted Therapy For MelanomaNational Cancer Institute2004–2008
- Targeted Therapy For MelanomaNational Cancer Institute2007
- Upcc #1698 Injections Of B7 1 In Patients W/ Metastatic MelanomaNational Center For Research Resources1999–2002
- Core--Clinical Research UnitNational Cancer Institute1996–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
